Identify the genetic basis of myopathies
Subgroup Leader : Valérie BIANCALANA
We study rare and severe neuromuscular disorders caused by mutations in proteins controlling intracellular organization and dynamics. We aim to tackle the three main bottlenecks in this field:
Identify the genetic basis of myopathies, myalgia and high athletic performances
Project leaders : Valérie BIANCALANA, Johann BOHM, Jocelyn LAPORTE
Understand and cure myotubular/centronuclear myopathies through gene modulation and pharmacology
Project leader : Jocelyn LAPORTE
Understand and cure tubular aggregates myopathy and Stormorken syndrome through gene modulation and pharmacology
Project leader : Johann BOHM
Subgroup Leader : Valérie BIANCALANA
Subgroup Leader : Jocelyn LAPORTE
Proceedings of the National Academy of Sciences of the United States of America ; Volume: 122
Disease Models & Mechanisms ; Volume: 18 ; Page: DMM052098
Acta Neuropathologica Communications ; Volume: 12 ; Page: 191
Cellular and Molecular Life Sciences ; Volume: 81 ; Page: 476
Médecine/Sciences ; Volume: 40 ; Page: 34-39
Cells ; Volume: 13 ; Page: 1829
Science ; Volume: 386
eLife ; Volume: 13 ; Page: RP95397
Genome Medicine ; Volume: 16 ; Page: 87
Trends in Molecular Medicine ; Volume: 30 ; Page: 579-591
Current fundings:
On February 27, the IGBMC opened its doors to several members of the Unistra Alumni Network, led by Agnès Villanueva (Director of Alumni Relations),…
Read more
Follow our publications and latest research on Researchgate : www.researchgate.net/profile/Jocelyn-Laporte
Raw data for our study on Multi-omics comparisons of different forms of centronuclear myopathies and the effects of several therapeutic strategies. Mol Ther. 2021 Apr 30:S1525-0016(21)00247-1.
www.ncbi.nlm.nih.gov/geo/query/acc.cgi
www.sciencedirect.com/science/article/abs/pii/S1525001621002471
In the press: